← The Wire
IRONNasdaq
Disc Medicine, Inc.
Pharmaceutical Preparations · CIK 1816736
Disc Medicine develops novel treatments for blood disorders by modifying red blood cell formation and iron balance
$2.60B
Market cap
$74.50
Last close
-0.4%
1D
+5.2%
5D
1.5M
Volume
Price · last 39 sessions+10.1%
May 4L $64.07 · H $74.78Jun 29
178
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 24, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KExit / Disposal CostsFeb 27, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureFeb 17, 20268-KReg FD Disclosure · Company UpdateFeb 13, 20268-KResults of Operations · Reg FD DisclosureJan 12, 2026SC 13D/ASC 13D/ADec 17, 20258-KCompany UpdateDec 8, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KMaterial Agreement · Company UpdateOct 22, 2025424B5424B5Oct 21, 2025424B5424B5Oct 20, 20258-KResults of Operations · Reg FD DisclosureOct 20, 20258-KCompany UpdateOct 17, 20258-KExecutive ChangeOct 6, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExecutive ChangeJul 14, 20258-KShareholder VoteJun 13, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KMaterial Agreement · Company UpdateJan 24, 2025424B5424B5Jan 23, 2025424B5424B5Jan 21, 20258-KReg FD Disclosure · Company UpdateJan 21, 20258-KReg FD Disclosure · Company UpdateJan 10, 20258-KCompany UpdateDec 9, 2024424B5424B5Nov 15, 20248-KMaterial Agreement · Agreement TerminatedNov 15, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSEC SCHEDULE 13GNov 8, 20248-KMaterial Agreement · New Debt / ObligationNov 8, 20248-KReg FD Disclosure · Company UpdateNov 4, 20248-KReg FD Disclosure · Company UpdateOct 25, 2024SC 13GSC 13GOct 24, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 2024SC 13GSC 13GJun 25, 20248-KShareholder VoteJun 14, 20248-KMaterial Agreement · Company UpdateJun 14, 2024424B5424B5Jun 14, 20248-KReg FD Disclosure · Company UpdateJun 14, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEF 14ADEF 14AMay 1, 2024DEFA14ADEFA14AMay 1, 20248-KReg FD Disclosure · Company UpdateApr 2, 202410-K10-KMar 21, 20248-KResults of OperationsMar 21, 20248-KReg FD DisclosureFeb 26, 20248-KExecutive Change · Reg FD DisclosureFeb 7, 20248-KReg FD Disclosure · Company UpdateDec 12, 20238-KReg FD Disclosure · Company UpdateDec 11, 20238-KMaterial AgreementDec 5, 2023424B5424B5Dec 5, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KReg FD Disclosure · Company UpdateNov 2, 20238-KExecutive ChangeOct 23, 20238-KMaterial AgreementOct 10, 2023424B5424B5Oct 10, 20238-KAgreement TerminatedSep 29, 2023SC 13GSC 13GSep 25, 20238-KResults of OperationsAug 11, 202310-Q10-QAug 11, 2023SC 13GDISC MEDICINE, INC.Jun 30, 20238-KMaterial Agreement · Company UpdateJun 16, 2023424B5424B5Jun 15, 2023
Insider Activity
In the 90 days to Mar 2, 2026: 7 sold $25.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sell | 4,392 | $65.52 | $288K |
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sell | 2,986 | $66.41 | $198K |
| Feb 25, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 353 | $69.06 | $24K |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 3,684 | $65.89 | $243K |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 3,397 | $65.01 | $221K |
| Feb 17, 2026 | Quisel John DChief Executive Officer | Sell | 13,264 | $62.86 | $834K |
| Feb 17, 2026 | Stephenson PamelaChief Commercial Officer | Sell | 5,531 | $62.86 | $348K |
| Feb 17, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 4,075 | $62.86 | $256K |
| Feb 17, 2026 | Savage William JacobChief Medical Officer | Sell | 3,256 | $62.86 | $205K |
| Feb 17, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sell | 3,231 | $62.86 | $203K |
| Feb 17, 2026 | Khara RahulChief Legal Officer | Sell | 2,853 | $62.86 | $179K |
| Jan 20, 2026 | Khara RahulChief Legal Officer | Sell | 1,000 | $69.74 | $70K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 4,993 | $78.62 | $393K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 1,157 | $79.27 | $92K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 350 | $77.67 | $27K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 393 | $91.47 | $36K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 213 | $91.47 | $19K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 148 | $91.47 | $14K |
| Dec 16, 2025 | Bitterman KevinDirector | Sell | 35,898 | $91.24 | $3.3M |
| Dec 16, 2025 | Bitterman KevinDirector | Sell | 18,666 | $91.24 | $1.7M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance